randomized double-blind placebo-controlled trial of acetyl-l-carnitine for als The Scientific and Therapeutic Rationale Off‐Label Treatments in Amyotrophic Lateral Sclerosis - Bedlack - 2025 Cancer Research UK | Randomised
Cancer Research UK Randomised trials The Scientific and Therapeutic Rationale for OffLabel Treatments in Amyotrophic Lateral Sclerosis Bedlack 2025 Annals of Neurology Wiley Online Library randomized double blind placebo controlled trial of acetyl l carnitine for als Clinical Evidence Efficacy in the Treatment of Acute Ischemic Stroke: A Pilot Clinical A phase 1, randomized double blind, A randomized double blind placebo controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID 19 ScienceDirect
Pay in 4 interest-free payments of $5.62 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23



